![]() |
市場調査レポート
商品コード
1447107
一般外科手術用デバイスの2030年までの市場予測:製品タイプ、技術、用途、エンドユーザー、地域別の世界分析General Surgical Devices Market Forecasts to 2030 - Global Analysis By Product, Type, Technology, Application, End User and by Geography |
||||||
カスタマイズ可能
|
一般外科手術用デバイスの2030年までの市場予測:製品タイプ、技術、用途、エンドユーザー、地域別の世界分析 |
出版日: 2024年03月03日
発行: Stratistics Market Research Consulting
ページ情報: 英文 200+ Pages
納期: 2~3営業日
|
Stratistics MRCによると、世界の一般外科手術用デバイス市場は2023年に174億4,000万米ドルを占め、予測期間中にCAGR 10.39%で成長し、2030年には348億4,000万米ドルに達すると予測されています。
現代のヘルスケアシステムにおいて、一般外科手術用デバイスは外科医が様々な作業を迅速かつ正確に実行するのに不可欠なツールです。メス、鉗子、ハサミ、リトラクター、止血材などの器具は、外科手術を容易にするために作られているため、このカテゴリーに含まれます。さらに、低侵襲性、回復期間の短縮、患者の転帰の改善など、ロボット支援手術システムや腹腔鏡器具などの低侵襲性手術器具は、技術の進歩によって可能になったものです。
米国外科学会によると、手術手技の進歩や一般手術機器への最先端技術の統合は、患者の転帰を改善し、技術革新を促進し、医療界全体の外科治療の水準を高めることに大きく貢献しています。
慢性疾患の増加と高齢化
一般外科手術用デバイス市場の主な促進要因は、がん、心血管障害、整形外科疾患などの慢性疾患の有病率の増加です。世界の人口が高齢化するにつれて、加齢に伴う健康問題で外科的介入を必要とする人の確率が高まっています。このような人口の変化や慢性疾患の蔓延が、一般外科手術用デバイスの必要性を高めています。さらに、これらの機器は、従来の器具から、複雑な外科手術をサポートする最先端技術まで多岐にわたります。
高額な費用と経済的制約
最先端手術技術の高価格は、一般手術機器市場の大きな障壁となっています。ヘルスケア施設にとって、ロボット手術システムのような最先端機器の取得と導入に伴う初期費用は法外なものとなる可能性があります。さらに、先進国や新興国市場では予算の制約からこれらの技術の導入が限定的であるため、市場全体の成長を阻害する可能性があります。この課題に対応するため、メーカーとヘルスケアプロバイダーは、費用対効果とイノベーションのバランスを取る必要があります。
低侵襲手術への要求の高まり
一般外科手術用デバイスの市場は、低侵襲手術法への傾斜が強まっていることから、大幅な成長が見込まれています。回復期間の短縮、手術後の痛みの軽減、入院期間の短縮は、すべて低侵襲手術の利点です。さらに、低侵襲手術を容易にするために作られた特殊な器具や装置の市場も拡大しており、こうした手術に対する患者の意識と需要が高まるにつれて、技術革新と市場成長が刺激されています。
厳しい規制環境
新しい器具の承認に遅れを生じさせる可能性のある規制の厳格化は、一般外科手術用デバイスの市場に脅威をもたらします。メーカー各社は、変化する規制要件に対応することの難しさに直面しており、これが新製品の発売を遅らせたり、規制要件を満たすための費用を増大させたりする原因となっています。さらに、規制の厳格な遵守は患者の安全を確保するために必要であるが、新型手術器具のタイムリーな発売を妨げるリスクにもなっています。
一般外科手術用デバイスの市場は、COVID-19の大流行によって大きく混乱し、供給側と需要側の両方に影響を及ぼしています。特にパンデミックの初期には、選択手術の延期やキャンセルによって手術器具の使用が減少しました。COVID-19症例の優先順位付けとリソースの再配分のため、ヘルスケア施設は通常業務の継続が困難になった。さらに、製造の遅れ、サプライチェーンの途絶、物流の制限などが市場の妨げとなった。しかし、ヘルスケアシステムが新たな基準に適応し、選択的手術の再開が優先されたため、パンデミックの後期には緩やかながらも着実な回復が見られました。
予測期間中、腹腔鏡下手術機器分野が最大となる見込み
一般外科手術用デバイス市場で最大の市場シェアを持つ腹腔鏡機器は、低侵襲外科治療に不可欠です。これらの器具には、腹腔鏡手術で使用されるカメラ、気腹器、特殊器具などの最先端技術が含まれ、患者の外傷を最小限に抑え、切開創を小さくすることができます。さらに、腹腔鏡機器の需要は、入院期間の短縮、術後の痛みの軽減、回復時間の短縮などの理由から、患者の低侵襲手術への嗜好が高まっていることが背景にあります。視覚化と精度の向上は、外科医がより効果的に仕事をこなし、患者に利益をもたらします。
予測期間中にCAGRが最も高くなると予想されるのは脳神経外科分野です。
力強くダイナミックな軌道を描く脳神経外科分野は、一般外科手術用デバイス市場において最も高いCAGRが見込まれています。神経外科の技術や器具の技術開発だけでなく、神経疾患の罹患率が上昇していることが、専門的な器具や機器の必要性を高めています。この分野は、ロボット支援神経外科システム、神経刺激装置、低侵襲処置などの技術革新により急速に拡大しています。さらに、神経外科用機器のニーズは、人口の高齢化や神経疾患に対する意識の高まりによっても高まっています。
洗練されたヘルスケアシステム、強固な規制枠組み、外科的介入を必要とする慢性疾患の罹患率の高さから、北米は現在、一般外科手術用デバイスの最大市場シェアを占めています。この地域の優位性は、技術革新と最先端の外科手術技術の採用を促進する研究開発への大規模な投資によるものです。一般外科手術用デバイスの普及は、業界大手の存在と強力な償還構造によって促進されています。さらに、人口の高齢化と低侵襲手術に対するニーズの高まりが、北米のこの市場の成長を促進しています。
一般外科手術用デバイス市場は、医療制度の急速な変化を反映して、アジア太平洋地域で最も高いCAGRでの成長が見込まれています。この著しい上昇には、慢性疾患の罹患率の増加、医療支出の増加、中国やインドなどの国における医療インフラの発展など、多くの要因が関わっています。この地域では人口が多く高齢化が進んでいるため、外科手術のニーズが高まっており、最先端の一般外科手術用デバイスの使用が促進されています。さらに、ヘルスケアの近代化と最先端技術の統合に重点が置かれていることも、この市場を前進させています。
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.
According to Stratistics MRC, the Global General Surgical Devices Market is accounted for $17.44 billion in 2023 and is expected to reach $34.84 billion by 2030 growing at a CAGR of 10.39% during the forecast period. In the modern healthcare system, general surgical instruments are essential tools that help surgeons execute a variety of tasks quickly and precisely. Devices such as scalpels, forceps, scissors, retractors, and hemostats are included in this category because they are made to make surgical procedures easier. Moreover, with less invasiveness, faster recovery periods, and better patient outcomes, minimally invasive surgical devices, such as robotic-assisted surgical systems and laparoscopic instruments, have been made possible by technological advancements.
According to the American Surgical Association, advancements in surgical techniques and the integration of cutting-edge technologies in general surgical devices have significantly contributed to improving patient outcomes, fostering innovation, and elevating the standards of surgical care across the medical landscape.
Growing chronic illness prevalence and aging population
The primary driver of the general surgical device market is the increasing prevalence of chronic diseases, including cancer, cardiovascular disorders, and orthopedic conditions. The probability of individuals needing surgical interventions for age-related health issues is increasing as the world's population ages. The need for general surgical devices is fueled by this shift in the population as well as the prevalence of chronic illnesses. Additionally, these devices can range from conventional instruments to cutting-edge technologies that support complex surgical procedures.
Expensive expenses and financial limitations
The high price of cutting-edge surgical technologies is a major barrier to the market for general surgical devices. For healthcare facilities, the upfront costs associated with acquiring and deploying state-of-the-art equipment, like robotic surgical systems, can be prohibitive. Furthermore, the limited adoption of these technologies due to budgetary constraints in developed and developing regions could potentially hinder the overall growth of the market. To meet this challenge, manufacturers and healthcare providers must strike a balance between cost-effectiveness and innovation.
Growing requirement for less invasive surgery
The market for general surgical devices is poised for substantial growth due to the growing inclination towards minimally invasive surgical methods. Fewer recovery periods, less pain following surgery, and shorter hospital stays are all advantages of minimally invasive procedures. Moreover, a growing market exists for specialized tools and devices made to facilitate minimally invasive surgeries, which is stimulating innovation and market growth as patient awareness and demand for these procedures increase.
Strictly regulated environment
Stricter regulations that may cause delays in the approval of new devices pose a threat to the market for general surgical devices. Manufacturers face difficulties adhering to changing regulatory requirements, which can cause delays in the launch of new products and escalate the expenses related to fulfilling regulatory requirements. Additionally, strict adherence to regulations is necessary to ensure patient safety, but it also poses a risk to the timely release of novel surgical devices.
The market for general surgical devices has been severely disrupted by the COVID-19 pandemic, affecting both the supply and demand sides. Especially in the early stages of the pandemic, a decrease in the use of surgical devices resulted from the postponement or cancellation of elective surgeries. Because of the prioritization of COVID-19 cases and the reallocation of resources, healthcare facilities encountered difficulties in continuing their regular operations. Further impeding the market were delays in manufacturing, disruptions in the supply chain, and logistical limitations. However, as healthcare systems adjusted to new standards and the resumption of elective surgeries was prioritized, the later stages of the pandemic saw a slow but steady recovery.
The Laproscopic Devices segment is expected to be the largest during the forecast period
With the largest market share in the general surgical devices market, laparoscopic instruments are essential to minimally invasive surgical treatments. These gadgets include cutting-edge technologies like cameras, insufflators, and specialty tools used in laparoscopic procedures, which minimize patient trauma and allow for smaller incisions. Moreover, laparoscopic device demand has been driven by patients increasing preference for minimally invasive procedures because of their shorter hospital stays, reduced postoperative pain, and faster recovery times. Improved visualization and precision help surgeons perform their jobs more effectively, which benefits patients.
The Neurosurgery segment is expected to have the highest CAGR during the forecast period
With a strong and dynamic trajectory, the neurosurgery segment is expected to have the highest CAGR in the general surgical device market. The need for specialized tools and equipment is driven by the rising incidence of neurological disorders as well as technological developments in neurosurgical techniques and apparatus. The field is expanding quickly due to innovations like robotic-assisted neurosurgery systems, neurostimulation devices, and minimally invasive procedures. Additionally, the need for neurosurgical devices is also fueled by an aging population and increased awareness of neurological disorders.
Due to its sophisticated healthcare system, solid regulatory framework, and high incidence of chronic illnesses requiring surgical interventions, North America presently commands the largest market share for general surgical devices. Large investments in R&D, which promote innovation and the adoption of state-of-the-art surgical technologies, are credited with the region's dominance. The widespread use of general surgical devices is facilitated by the existence of major industry participants and a strong reimbursement structure. Furthermore, the aging population and the rising need for minimally invasive surgical procedures are driving the growth of this market in North America.
The general surgical devices market is expected to grow at the highest CAGR in the Asia-Pacific region, reflecting the rapidly changing nature of the healthcare system. This remarkable rise is being fueled by a number of factors, including the growing incidence of chronic illnesses, rising healthcare spending, and developing healthcare infrastructure in nations like China and India. Due to the regions large and aging population, there is an increasing need for surgical procedures, which is encouraging the use of cutting-edge general surgical instruments. Additionally, the market is advanced by the emphasis on modernizing healthcare and the integration of cutting-edge technologies.
Key players in the market
Some of the key players in General Surgical Devices market include B. Braun Melsungen AG, Medtronic Plc, Olympus Corporation, 3M Healthcare, Cadence Inc, Boston Scientific Corporation, Cook Medical Inc., Dickinson and Company, Abbott Laboratories, Siemens Healthcare GmbH, Johnson & Johnson Service Inc., Becton, Integra LifeSciences, Conmed Corporation, Hoffmann-La Roche, Stryker Corporation, Erbe Elektromedizin Gmbh, Zimmer Biomet Holdings, Inc. and Teleflex Incorporated.
In May 2023, Medtronic plc, a global leader in healthcare technology, today announced it has entered into a set of definitive agreements to acquire EOFlow Co. Ltd., manufacturer of the EOPatch(R) device - a tubeless, wearable and fully disposable insulin delivery device. The addition of EOFlow, together with Medtronic's Meal Detection Technology(TM) algorithm and next-generation continuous glucose monitor (CGM), is expected to expand the company's ability to address the needs of more individuals with diabetes, no matter where they are in their treatment journey or preference for how they want their insulin delivered.
In May 2023, 3M announced it has entered into agreements to sell certain assets associated with its dental local anesthetic portfolio, based in Seefeld, Germany, to Pierrel S.p.A. ("Pierrel"), a global provider of services for the pharmaceutical industry, for a purchase price of $70 million, subject to closing and other adjustments.
In July 2023, Cadence Design Systems, Inc. and Rambus Inc., a premier chip and silicon IP provider making data faster and safer, today announced that they have entered into a definitive agreement for Cadence to acquire the Rambus SerDes and memory interface PHY IP business. Rambus will retain its digital IP business, including memory and interface controllers and security IP.